SCHEMBL30107744

SCHEMBL30107744

c1ccc(-c2cc(-c3ccccc3)nc(-c3cc(-n4c5ccc(-n6c7ccccc7c7ccccc76)cc5c5cc(-n6c7ccccc7c7ccccc76)ccc54)cc(-n4c5ccc(-n6c7ccccc7c7ccccc76)cc5c5cc(-n6c7ccccc7c7ccccc76)ccc54)c3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.42
▸ L3MBTL1 Q9Y468 3/20 0.42
▸ ATM Q13315 2/20 0.42
▸ MEN1 O00255 8/20 0.40
▸ KMT2A Q03164 8/20 0.40
▸ MAPT P10636 7/20 0.40
▸ HPGD P15428 6/20 0.40
▸ ALDH1A1 P00352 6/20 0.40
▸ NTSR1 P30989 1/20 0.40
▸ LMNA P02545 3/20 0.38
▸ RAC2 P15153 1/20 0.38
▸ RAC3 P60763 1/20 0.38
▸ CDC42 P60953 1/20 0.38
▸ RAC1 P63000 1/20 0.38
▸ ADORA2A P29274 2/20 0.37
▸ ADORA1 P30542 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ ACHE P22303 1/20 0.36
▸ GLA P06280 1/20 0.35
▸ TDP1 Q9NUW8 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21215184 1.00 KDM4E (0.42) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL30107896 1.00 KDM4E (0.42) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL21196549 1.00 KDM4E (0.42) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL30107875 0.96 MEN1 (0.42) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL24677466 0.95 KDM4E (0.40) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL24677447 0.93 MEN1 (0.40) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL24677113 0.93 MEN1 (0.40) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL804824 0.93 KDM4E (0.48) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL15257567 0.92 KDM4E (0.46) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL16689506 0.92 KDM4E (0.46) KDM4EL3MBTL1ATMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542260-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-01-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11542260-B2 Composition of matter for use in organic light-emitting diodes CRY2, NDUFV3, SLCO1B3 KDM4E 4295/4885L3MBTL1 1078/4885ATM 1898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback